Tixagevimab/Cilgavimab does not prevent COVID-19 in patients with multiple sclerosis and related disorders on B-cell depleting therapies
S Conway, S Gupta, B Healy, TY Chuang… - Multiple Sclerosis and …, 2024 - Elsevier
Background Patients with MS and related disorders (pwMSARD) on B-cell depleting
treatments have attenuated immune responses to vaccination and were eligible to receive …
treatments have attenuated immune responses to vaccination and were eligible to receive …